DDW: Rifaximin Cuts Peritonitis in Cirrhosis (CME/CE)
CHICAGO (MedPage Today) — The nonabsorbable antibiotic rifaximin appeared to reduce the incidence of bacterial peritonitis in patients with advanced liver cirrhosis, according to a study presented here.
Article printed from Gastroenterology Education and CPD for trainees and specialists: https://www.gastrotraining.com